Myriad Genetics
MYGN
#6699
Rank
NZ$1.14 B
Marketcap
NZ$12.27
Share price
-3.27%
Change (1 day)
-55.87%
Change (1 year)

Myriad Genetics (MYGN) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$1.26 Billion

According to Myriad Genetics's latest financial reports the company's total assets are NZ$1.26 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Myriad Genetics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$1.82 B0.5%
2023-12-31NZ$1.81 B-3.98%
2022-12-31NZ$1.88 B-2.36%
2021-12-31NZ$1.93 B
2020-06-30NZ$2.17 B-6.33%
2019-06-30NZ$2.32 B33.93%
2018-06-30NZ$1.73 B5.1%
2017-06-30NZ$1.65 B33.83%
2016-06-30NZ$1.23 B9.29%
2015-06-30NZ$1.12 B20.08%
2014-06-30NZ$0.94 B-9.5%
2013-06-30NZ$1.03 B20.71%
2012-06-30NZ$0.86 B16.71%
2011-06-30NZ$0.73 B-14.11%
2010-06-30NZ$0.85 B18.01%
2009-06-30NZ$0.72 B10.83%
2008-06-30NZ$0.65 B34.36%
2007-06-30NZ$0.48 B6.96%
2006-06-30NZ$0.45 B96.52%
2005-06-30NZ$0.23 B-21.09%
2004-06-30NZ$0.29 B-6.22%
2003-06-30NZ$0.31 B-3.03%
2002-06-30NZ$0.32 B-23.52%
2001-06-30NZ$0.42 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Bio-Rad Laboratories
BIO
NZ$16.78 B 1,231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
NZ$10.21 B 710.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ$38.26 M-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$13.18 B 945.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$145.71 B 11,461.74%๐Ÿ‡บ๐Ÿ‡ธ USA